SAKK at American Society of Clinical Oncology (ASCO) Virtual Meeting 2020

Lung cancer trial SAKK 16/14

SAKK at American Society of Clinical Oncology (ASCO) Virtual Meeting 2020

Lung cancer trial SAKK 16/14

We are proud to inform you about the SAKK trial presented during the ASCO Annual Meeting 2020, May 29 - 31.

The abstract listed below has been accepted for Poster discussion:

  • Sacha Rothschild et al.: SAKK 16/14: Anti-PD-L1 antibody durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm phase II trial.

Further information about this poster discussion: 
https://meetinglibrary.asco.org/record/184538/abstract.

PD Dr. med. Dr. phil. nat.
Sacha
Rothschild
Board Member

SAKK 16/14 Poster ASCO2020

All News